![]() | HIV in Pregnancy: A Review (UNAIDS, 1999, 67 p.) |
![]() |
|
UNAIDS
WHO
ACKNOWLEDGEMENTS
This paper was prepared by James Mclntyre, Perinatal HIV Research Unit, Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa. Additional editing and input was provided by Peter Brocklehurst, Oxford National Perinatal Epidemiology Unit. A working group on HIV in pregnancy, composed of staff from the World Health Organization's Department of Reproductive Health and Research, and the Joint United Nations Programme on HIV/AIDS, oversaw this work and the subsequent review of the paper.
Cover design: Me Nhear
© World Health Organization, 1999
© Joint United
Nations Programme on HIV/AIDS, 1999
This document is not a formal publication of the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS), but all rights are reserved by these agencies. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.
The views expressed in documents by named authors are solely the responsibility of those authors.
For authorization to translate the work in full, and for any use by commercial entities, application and enquiries should be addressed to Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and the reprint and translations that are already available.
The designations employed and the presentation of the material in this work do not imply the expression of any opinion whatsoever on the part of WHO and UNAIDS concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers and boundaries.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
GLOSSARY OF ACRONYMS
3TC |
Lamivudine |
ADCC |
Antibody-dependent cellular cytotoxicity |
AIDS |
Acquired Immune Deficiency Syndrome |
ARV |
Antiretroviral |
AZT |
Azidothymidine (zidovudine) |
CD4+ |
Cluster designation 4 positive lymphocytes |
CD8 |
Cluster designation 8 positive lymphocytes |
DNA |
Deoxyribonucleic acid |
ECS |
European Collaborative Study |
ELISA |
Enzyme-linked immunoabsorbent assay |
FDA |
Food and Drug Administration, United States of America |
HBV |
Hepatitis B virus |
HIV |
Human Immunodeficiency Virus |
HIV-1 |
Human Immunodeficiency Virus Type 1 |
HIV-2 |
Human Immunodeficiency Virus Type 2 |
HIVIG |
Hyper-immune HIV immunoglobulin |
HLA |
Human leukocyte antigen |
IgA |
Immunoglobulin A |
IgM |
Immunoglobulin M |
IVIG |
Intravenous immunoglobulin |
MTCT |
Mother-to-child transmission |
NNRTI |
Non-nucleoside reverse transcriptase inhibitor |
NSI |
Non-syncytium-inducing |
PACTG |
Pediatric AIDS Clinical Trials Group |
PCP |
Pneumocystis carinii pneumonia |
PCR |
Polymerase Chain Reaction |
PETRA |
Perinatal Transmission Study (UNAIDS) |
RNA |
Ribonucleic acid |
SI |
Syncytium-inducing |
SLPI |
Secretory leukocyte protease inhibitor |
STI |
Sexually transmitted infection |
UNAIDS |
Joint United Nations Programme on HIV/AIDS |
UNICEF |
United Nations Children's Fund |
USA |
United States of America |
WHO |
World Health Organization |
WITS |
Women and Infants Transmission Study |
ZDV |
Zidovudine |